ICHA · Registering as Listener

International Conference on HIV and AIDS

13th Nov – 14th Nov 2026 Braga, Portugal Standard / Physical Participation
Listener Registration From
$—
$— in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

For Support Please Contact

Coupon code

Have a code? Apply it here — the discount updates the total immediately.

Apply
VISA MC AMEX UPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceICHA
ModeStandard / Physical
ParticipationListener
Registration fee$—
Bank charges (5.8%)$—
Discount-$0.00
Total payable $—

Includes all bank processing charges — the amount above is exactly what will be charged. View charge breakdown

Need help?

Contact our registration team:

Benefits of Registering as Listener
Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
Conference Session Tracks
SDG Wheel

SDG-Aligned Research Themes

International Conference on HIV and AIDS conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 10 - Reduced Inequalities

This track focuses on the latest breakthroughs in the discovery and development of antiretroviral therapies for HIV. Researchers will present novel compounds and innovative approaches to enhance treatment efficacy and reduce resistance.

This session will explore contemporary issues in virology, particularly concerning HIV and other retroviral diseases. Participants will discuss emerging research findings and their implications for public health strategies.

This track examines the unique epidemiological patterns of HIV/AIDS across Afro-Asian regions. Discussions will highlight socio-economic factors influencing transmission rates and the effectiveness of intervention strategies.

This session will delve into the mechanisms of primary HIV infection and the factors affecting transmission. Researchers will present data on viral load, risk behaviors, and potential eradication strategies.

This track addresses the intersection of drug abuse and HIV infection, focusing on neurocognitive implications. Experts will discuss the impact of substance use on HIV progression and treatment outcomes.

This session will highlight cutting-edge diagnostic techniques and therapeutic approaches for managing HIV. Presentations will cover advancements in point-of-care testing and personalized medicine.

This track will focus on community-based interventions and social strategies aimed at reducing HIV transmission. Participants will share successful case studies and discuss the role of education and advocacy.

This session will explore pharmaceutical strategies for the prevention of HIV and other sexually transmitted diseases. Researchers will discuss the efficacy of pre-exposure prophylaxis (PrEP) and other preventive measures.

This track investigates the biological mechanisms underlying HIV sanctuaries and reservoirs in the body. Presentations will focus on strategies to target these reservoirs for effective viral control.

This session will examine the significance of cellular viral load in the context of HIV management. Researchers will discuss its role in treatment decisions and long-term health outcomes.

This track will address the essential components of sexual health services within Federally Qualified Health Centers. Discussions will focus on best practices for integrating HIV prevention and care into primary health services.

COPYRIGHT © 2026 International Conference on HIV and AIDS. ALL RIGHTS RESERVED